Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Gastrointestinal Neoplasms 3Stomach Neoplasms 2Esophageal Neoplasms 2Urinary Bladder Neoplasms 1Peritoneal Neoplasms 1Appendiceal Neoplasms 1

Interventions

Oxaliplatin 11Mitomycin 11Leucovorin 7Hyperthermic Intraperitoneal Chemotherapy 7Irinotecan 6Fluorouracil 6Cisplatin 4Capecitabine 4Surveys and Questionnaires 3Doxorubicin 3Cytoreduction Surgical Procedures 3dehydroftorafur 2Trastuzumab 2Thalidomide 2Mitozytrex 2Melphalan 2Interleukin-12 Subunit p35 2Floxuridine 2Drug Therapy 2Cetuximab 2Biopsy 2tipifarnib 1surufatinib 1sodium thiosulfate 1sintilimab 1nintedanib 1nilotinib 1motexafin lutetium 1irinotecan sucrosofate 1entinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Appendiceal Neoplasms × Pafolacianine × Gastrointestinal × Clear all
NCT07124351 2025-09-15

Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUXâ„¢)

Cedars-Sinai Medical Center

Phase 4 Recruiting
15 enrolled
Gastrointestinal

Appendiceal Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡